Functional genetic variants in immune-checkpoint molecules and susceptibility to Nasopharyngeal carcinoma in a

Wejden Gharbi1, Wicem Siala2, Olfa Abida3

  • 1Autoimmunity, Cancer, and Immunogenetics Research Laboratory (LR18SP12), Immunology Department, Habib Bourguiba University Hospital, Sfax, Tunisia. gharbi.wejden1995@gmail.com.

Molecular Biology Reports
|December 29, 2025
PubMed
Abstract

Insights

Genetic variations in CTLA-4 (rs231775) and CD274 (rs2890658) are associated with increased nasopharyngeal carcinoma (NPC) risk in Tunisia. These findings highlight potential genetic predisposition factors for NPC.

Area of Science:

  • Immunogenetics
  • Cancer Epidemiology
  • Molecular Biology

Background:

  • Immune checkpoint pathways (CTLA-4, PD-1, PD-L1) are crucial in cancer therapy.
  • Genetic variations in these pathways can influence cancer risk and treatment outcomes.

Purpose of the Study:

  • To investigate the association between common immune gene polymorphisms and nasopharyngeal carcinoma (NPC) susceptibility in Tunisia.
  • To identify specific genetic markers that may predispose individuals to NPC.

Main Methods:

  • A case-control study involving 61 Tunisian NPC patients and 150 healthy controls.
  • Analysis of six polymorphisms in CTLA-4, PDCD1, and CD274 genes using PCR-RFLP.
  • Statistical analysis including genotype, haplotype, and phenotype-genotype associations.

Main Results:

  • The CTLA-4 rs231775 AA genotype showed a significant association with increased NPC susceptibility (OR=2.5).
  • A specific risk haplotype (rs231775-A, rs3087243-A, rs36084323-G, rs2227982-C, rs2227981-C) was more prevalent in NPC patients (OR=1.64).
  • The CD274 rs2890658 CC genotype was strongly associated with increased NPC risk (OR=3.2), with the C allele conferring a 2.4-fold higher risk.

Conclusions:

  • CTLA-4 rs231775 AA and CD274 rs2890658 CC genotypes may serve as predisposition factors for NPC.
  • These genetic variations could inform future research on NPC pathogenesis.
  • CTLA-4, PDCD1, and CD274 warrant further investigation as potential personalized therapeutic targets in NPC.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K